INGALLS & SNYDER LLC – Corcept Therapeutics Incorporated Transaction History
INGALLS & SNYDER LLC portfolio value:
$178.22M
portfolio value
INGALLS & SNYDER LLC quarter portfolio value change:
+7.82%
quarter
Corcept Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.59% | -41.17K shares | 11.95M | $25.64 | 6.95M |
| Q2 2022 | share | Increase | +1.17% | 80.87K shares | 10.63M | $23.78 | 6.99M |
| Q1 2022 | share | Increase | +2.57% | 173.47K shares | 22.23M | $22.52 | 6.91M |
| Q4 2021 | share | Decrease | -4.47% | -315.47K shares | -5.4M | $19.48 | 6.73M |
| Q3 2021 | share | Decrease | -0.25% | -17.78K shares | -16.75M | $19.68 | 7.05M |
| Q2 2021 | share | Increase | +1.79% | 124.42K shares | -9.69M | $22 | 7.07M |
| Q1 2021 | share | Decrease | -4.87% | -355.58K shares | -25.76M | $23.79 | 6.94M |
| Q4 2020 | share | Decrease | -2.53% | -189.43K shares | 60.63M | $26.16 | 7.30M |
| Q3 2020 | share | Decrease | -1.42% | -107.53K shares | 2.57M | $17.41 | 7.49M |
| Q2 2020 | share | Decrease | -5.05% | -404.43K shares | 32.65M | $16.82 | 7.59M |
| Q1 2020 | share | Decrease | -0.13% | -10.62K shares | -1.81M | $11.89 | 8.00M |
| Q4 2019 | share | Decrease | -8.01% | -697.82K shares | -26.17M | $12.1 | 8.01M |
| Q3 2019 | share | Increase | +2.23% | 190.37K shares | 28.12M | $14.14 | 8.71M |
| Q2 2019 | share | Increase | +1.79% | 149.79K shares | -3.26M | $11.15 | 8.52M |
| Q1 2019 | call | Decrease | -100.00% | -20K shares | -267K | $11.74 | 0 |
| Q1 2019 | share | Decrease | -0.02% | -1.88K shares | -13.58M | $11.74 | 8.37M |
| Q4 2018 | call | 0.00% | 0 shares | -13K | $13.36 | 20K | |
| Q4 2018 | share | Decrease | -0.29% | -24.37K shares | -5.86M | $13.36 | 8.37M |
| Q3 2018 | share | Increase | +14.78% | 1.08M shares | 2.72M | $14.02 | 8.39M |
| Q3 2018 | call | Increase | 0.00% | 20K shares | 280K | $14.02 | 20K |
| Q2 2018 | share | Increase | +7.33% | 499.45K shares | 2.87M | $15.72 | 7.31M |
| Q1 2018 | share | Decrease | -1.53% | -106.15K shares | -12.89M | $16.45 | 6.81M |
| Q4 2017 | share | Increase | +0.65% | 44.59K shares | -7.72M | $18.06 | 6.92M |
| Q3 2017 | share | Decrease | -5.93% | -433.53K shares | 46.47M | $19.3 | 6.87M |
| Q2 2017 | share | Decrease | -6.76% | -530.2K shares | 332K | $11.8 | 7.31M |
| Q1 2017 | share | Decrease | -3.88% | -316.84K shares | 26.71M | $10.96 | 7.84M |
| Q4 2016 | share | Decrease | -5.22% | -449.75K shares | 3.27M | $7.26 | 8.15M |
| Q3 2016 | share | Decrease | -6.10% | -558.81K shares | 5.90M | $6.5 | 8.60M |
| Q2 2016 | share | Increase | 0.00% | 9.16M shares | 50.05M | $5.46 | 9.16M |